TFS
RMD icon

Thoroughbred Financial Services’s ResMed RMD Stock Holding History

Thoroughbred Financial Services’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-752
Closed -$205K – 599
2025
Q3 		$205K Buy
+752
New +$205K 0.01% 554
2022
Q1 		– Sell
-2,791
Closed -$727K – 380
2021
Q4 		$727K Buy
2,791
+3
+0.1% +$778 0.15% 148
2021
Q3 		$734K Buy
2,788
+654
+31% +$179K 0.18% 129
2021
Q2 		$526K Buy
+2,134
New +$449K 0.13% 163

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Thoroughbred Financial Services's RMD Position: Q4 2025 in Review

Thoroughbred Financial Services sold out of ResMed (RMD) in Q4 2025, closing a stake of 752 shares — an estimated $205K sold.

Thoroughbred Financial Services first reported a position in RMD in Q2 2021 and held it in 4 quarters. The position peaked at $734K in Q3 2021. 945 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Thoroughbred Financial Services reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Thoroughbred Financial Services sold 752 ResMed shares in Q4 2025, an estimated $205K.
  • Thoroughbred Financial Services first reported a position in ResMed in Q2 2021 and held it in 4 quarters.
  • Thoroughbred Financial Services's ResMed position peaked at $734K in Q3 2021.
  • 945 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Thoroughbred Financial Services's 13F filing for Q4 2025, filed 10 Feb 2026.